About Michael Cannon
Form D filings for Eureka Therapeutics from 2016 to 2023 list Michael Cannon as director.
Michael Cannon first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Cannon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Cannon works with at each company, as listed on that company's latest Form D.
Eureka Therapeutics, Inc. · Form D, May 17, 2023
VC
Vivien Chan
Executive officer
CL
Cheng Liu
Executive officer and director
MS
Marvin Samson
Director
WI
William Solari III
Director
WC
Wai-Yan "Sandy" Chau
Director
RJ
Reed Jobs
Director
VS
Victor Shum
General Counsel
JN
Jacqueline Northcut
Director
CC
Chih-Kai "C.K. Cheng
Director